CCME Global share news and announcements
BSE: 514336Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹31.81.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹137 Cr2,307th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −3.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −2.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,296
CCME Global share news and announcements
551 announcements, routine notices left out, newest first. Page 4 of 12.
Nov 2023
6 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results
Sep 2023
30 Sep · Meeting
Aug 2023
8 Aug · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
1 Aug · Board meeting
Meeting on 8 Aug 2023: quarterly results
Jun 2023
May 2023
22 May · Related Party Transactions Disclosure Under Regulation 23(9)
15 May · Board meeting
Meeting on 22 May 2023: quarterly results and audited results
Apr 2023
14 Apr · Compliance Certificate Under Regulation 7(3) For FY Ended 2022-23
Jan 2023
24 Jan · Board meeting
Meeting on 31 Jan 2023: quarterly results
Nov 2022
21 Nov · Related Party Transactions - Reg 23(9)
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
Sep 2022
Aug 2022
30 Aug · Board meeting
Meeting on 3 Sep 20222 Aug · Board meeting
Meeting on 10 Aug 2022: quarterly results
Jul 2022
20 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2022
30 May · Related Party Transactions FY 2021-22
23 May · Board meeting
Meeting on 30 May 2022: audited results
Apr 2022
21 Apr · Compliance Certificate For The Period Ended 31.03.2022
16 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0